BUSINESS SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Product Revenues [Table Text Block]

Product revenues and the composition of total revenues were as follows:

	Three Months Ended March 31,
Dollars in Millions	2017		2016
Prioritized Brands
Opdivo	$	1,127	$	704
Eliquis	1,101		734
Orencia	535		475
Sprycel	463		407
Yervoy	330		263
Empliciti	53		28
Established Brands
Hepatitis C Franchise	162		427
Baraclude	282		291
Sustiva Franchise	184		273
Reyataz Franchise	193		221
Other Brands	499		568
Total Revenues	$	4,929	$	4,391
Net product sales	$	4,580	$	3,964
Alliance revenues	297		409
Other revenues	52		18
Total Revenues	$	4,929	$	4,391